Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Albumin-Bound Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma: NCT07622797 Clinical Landscape Report 2026
16 October 2026
NCT07622797 clinical landscape for Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
TROP2-CAR-NK(M.D. Anderson Cancer Center) in Squamous Cell Carcinoma of Head and Neck: NCT07631013 Clinical Landscape Report 2026
16 October 2026
NCT07631013 clinical landscape for Squamous Cell Carcinoma of Head and Neck: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Toripalimab in Nasopharyngeal Neoplasms: NCT07625423 Clinical Landscape Report 2026
16 October 2026
NCT07625423 clinical landscape for Nasopharyngeal Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
UBT38006 in Diabetes Mellitus, Type 2: NCT07630233 Clinical Landscape Report 2026
16 October 2026
NCT07630233 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Adrenaline in Diabetes Mellitus, Type 2: NCT07633106 Clinical Landscape Report 2026
16 October 2026
NCT07633106 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Indocyanine Green in Soft Tissue Injuries: NCT07635420 Clinical Landscape Report 2026
16 October 2026
NCT07635420 clinical landscape for Soft Tissue Injuries: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Calcium Phosphate in Diabetes Mellitus, Type 2: ACTRN12626000683336 Clinical Landscape Report 2026
16 October 2026
ACTRN12626000683336 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Tadalafil in Diabetes Mellitus, Type 2: NCT07636161 Clinical Landscape Report 2026
16 October 2026
NCT07636161 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pirfenidone in MSS/pMMR/MSI-L Colorectal Carcinoma: NCT07644286 Clinical Landscape Report 2026
16 October 2026
NCT07644286 clinical landscape for MSS/pMMR/MSI-L Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Phentermine Hydrochloride/Topiramate in Diabetes Mellitus, Type 2: ACTRN12626000702314 Clinical Landscape Report 2026
16 October 2026
ACTRN12626000702314 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
VCT220 in Obesity: NCT07652047 Clinical Landscape Report 2026
16 October 2026
NCT07652047 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cemiplimab-RWLC in Nasopharyngeal Carcinoma: NCT07650266 Clinical Landscape Report 2026
16 October 2026
NCT07650266 clinical landscape for Nasopharyngeal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.